Abstract:The fat mass and obesity-associated enzyme (FTO) can catalyze the demethylation of N6-methyladenosine (m6A) residues in mRNA, regulates the cellular level of m6A modification, and plays a critical role in human obesity and cancers. Herein, we develop a single-quantum-dot (QD)-based fluorescence resonance energy transfer (FRET) sensor for the identification of specific FTO demethylase inhibitors. The FTO-mediated demethylation of m6A can induce the cleavage of demethylated DNA to generate the biotinylated DNA fragments, which may function as capture probes to assemble the Cy5-labeled reporter probes onto the QD surface, enabling the occurrence of FRET between the QD and Cy5. The presence of inhibitors can inhibit the FTO demethylation and consequently abolish FRET between the QD and Cy5. The inhibition effect of inhibitors upon FTO demethylation can be simply evaluated by monitoring the decrease of Cy5 counts. We use this nanosensor to screen several small-molecule inhibitors and identify diacerein as a highly selective inhibitor of FTO. Diacerein can inhibit the demethylation activity of endogenous FTO in HeLa cells. Interestingly, diacerein is neither a structural mimic of 2-oxoglutarate (2-OG) nor a chelator of metal ions, and it can selectively inhibit FTO demethylation by competitively binding the m6A-containing substrate.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02828?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02828</a>.Sequence of oligonucleotides and the optimization of experimental conditions (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02828/suppl_file/ac0c02828_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Strategy Based on Nucleotide Specificity Leads to a Subfamily-Selective and Cell-Active Inhibitor of N6-methyladenosine Demethylase FTO.

Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor.

Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors

Identification of Specific N 6 -Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors

Structural Insights into FTO's Catalytic Mechanism for the Demethylation of Multiple RNA Substrates

Identification of Specific N6-Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors.

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates

A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities

Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.

A Demethylation-Switchable Aptamer Design Enables Lag-Free Monitoring of M6a Demethylase FTO with Energy Self-Sufficient and Structurally Integrated Features.

Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development

Construction of a N6-Methyladenosine Demethylation-Switched Deoxyribozyme Circuit for in Vitro and in Situ Detection of FTO Activity

Demethylase FTO activity analysis based on methyl sensitive enzyme MazF and hybridization chain reaction

Discovery of a Potent, Selective and Cell Active Inhibitor of M6a Demethylase ALKBH5.

Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors

A far red emissive RNA aptamer-fluorophore system for demethylase FTO detection: design and optimization

Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties

Identification of Natural Compound Radicicol As a Potent FTO Inhibitor.

Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy